|
Market Closed -
Euronext Paris
03:55:00 10/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.0750 EUR | 0.00% |
|
0.00% | -43.61% |
| 30/10 | IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 12/10 | ABL Texcell Diagnostics to Acquire French Biotech Company IntegraGen | MT |
Company Valuation: IntegraGen
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 |
|---|---|---|
| Market Cap 1 | 6.536 | 13.61 |
| Change | - | 108.2% |
| Enterprise Value (EV) 1 | 4.017 | 10.5 |
| Change | - | 161.33% |
| P/E | -23x | -36.6x |
| PBR | 2.61x | 6.28x |
| PEG | - | -1.3x |
| Capitalization / Revenue | 0.79x | 1.51x |
| EV / Revenue | 0.49x | 1.17x |
| EV / EBITDA | -37.6x | -375x |
| EV / EBIT | -11.1x | -41.2x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | -0.0439 | -0.0559 |
| Distribution rate | - | - |
| Net sales 1 | 8.28 | 9 |
| EBITDA 1 | -0.107 | -0.028 |
| EBIT 1 | -0.3631 | -0.255 |
| Net income 1 | -0.2848 | -0.375 |
| Net Debt 1 | -2.519 | -3.109 |
| Reference price 2 | 1.0100 | 2.0500 |
| Nbr of stocks (in thousands) | 6,471 | 6,638 |
| Announcement Date | 3/4/20 | 11/6/21 |
1EUR in Million2EUR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 551K | ||
| 17.43x | 6.68x | 12.81x | 1.71% | 66.7B | ||
| 30.07x | 8.27x | 26.77x | 0.07% | 56.88B | ||
| 38.45x | 6.84x | 20.45x | 0.85% | 56.53B | ||
| 46.55x | 6.14x | 30.16x | -.--% | 46.49B | ||
| 35.48x | 3.35x | 14.48x | -.--% | 44.8B | ||
| -22.71x | 62.58x | -21.48x | -.--% | 41.59B | ||
| 35.87x | 8.84x | 23.03x | 0.37% | 35.35B | ||
| 41.46x | 8.08x | 26.8x | -.--% | 33.29B | ||
| -69.81x | 13.21x | -71.01x | -.--% | 25.1B | ||
| Average | 16.98x | 13.78x | 6.89x | 0.33% | 41B | |
| Weighted average by Cap. | 21.52x | 12.92x | 11.34x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALINT Stock
- Valuation IntegraGen
Select your edition
All financial news and data tailored to specific country editions
















